Literature DB >> 9672067

Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening.

S Kikuchi1, K Umemura, K Kondo, A R Saniabadi, M Nakashima.   

Abstract

We have established a mouse model of intimal thickening and assessed its suitability for experimental studies of intimal thickening. Neointimal formation was observed after endothelial injury by photochemical reaction between transluminal green light and systemically administered rose Bengal, which represents a nonmechanical approach to vessel wall denudation. Intimal thickening began 7 days after endothelial injury, reached a maximum after 21 days, and then remained unchanged for as long as 42 days. Furthermore, as a consequence of neointimal proliferation, the luminal area gradually decreased. The cells in the neointimal layer were identified as smooth muscle cells by immunohistochemical staining with an alpha-actin-specific antibody. Extracellular matrix deposition in the neointima was markedly increased beyond 14 days after injury. Smooth muscle cell proliferation, as measured by pulse labeling of 5-bromo-2'-deoxyuridine, was identified initially in the media 2 days after vessel wall denudation, with the proliferative activity's shifting almost exclusively to the neointima within 7 days. Endothelial regeneration, as indicated by Evans blue staining, was complete within 21 days after injury. To assess the suitability of this model for experimental studies on intimal thickening, the effect of tranilast, an antiallergy drug with a broad spectrum of pharmacological actions on intimal thickening, was investigated. Tranilast (100 mg x kg(-1) x d(-1) p.o.) significantly (P<0.05) reduced smooth muscle cell proliferation in the neointima and media 7 days after injury and neointimal formation 21 days after injury in treated mice compared with vehicle-treated mice. This simple experimental mouse model is suitable for studying factors promoting or inhibiting intimal thickening after endothelial injury and for developing therapeutic strategies against intimal thickening.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672067     DOI: 10.1161/01.atv.18.7.1069

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  11 in total

1.  Human solCD39 inhibits injury-induced development of neointimal hyperplasia.

Authors:  J H F Drosopoulos; R Kraemer; H Shen; R K Upmacis; A J Marcus; E Musi
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

2.  Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors.

Authors:  S Watanabe; A Matsuda; Y Suzuki; K Kondo; Y Ikeda; H Hashimoto; K Umemura
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty.

Authors:  D I Simon; Z Dhen; P Seifert; E R Edelman; C M Ballantyne; C Rogers
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

4.  Ferric Chloride-induced Thrombosis Mouse Model on Carotid Artery and Mesentery Vessel.

Authors:  Thomas Bonnard; Christoph E Hagemeyer
Journal:  J Vis Exp       Date:  2015-06-29       Impact factor: 1.355

Review 5.  Animal, in vitro, and ex vivo models of flow-dependent atherosclerosis: role of oxidative stress.

Authors:  Amir Rezvan; Chih-Wen Ni; Noah Alberts-Grill; Hanjoong Jo
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

6.  The Antithrombotic Effect of Recombinant Neorudin on Thrombi.

Authors:  Yu-Bin Liu; Lin Zhang; Xing-Chen Zhou; Ying Zhou; Yun Liu; Can Zheng; Xiao Xu; Pan-Pan Geng; Chun-Hua Hao; Zhuan-You Zhao; Chu-Tse Wu; Ji-De Jin
Journal:  Drug Des Devel Ther       Date:  2022-06-02       Impact factor: 4.319

7.  Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.

Authors:  Yan Ji; Zhen Weng; Philip Fish; Neha Goyal; Mao Luo; Samantha P Myears; Tammy L Strawn; Bysani Chandrasekar; Jianbo Wu; William P Fay
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-22       Impact factor: 8.311

8.  A rat model of thrombosis in common carotid artery induced by implantable wireless light-emitting diode device.

Authors:  Jih-Chao Yeh; Kuo-Lun Huang; Yung-Chin Hsiao; Yu-Han Hsu; Yun-Han Lin; Shyh-Liang Lou; Tsong-Hai Lee
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

9.  Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo.

Authors:  Stefania Momi; Emanuela Falcinelli; Silvia Giannini; Loredana Ruggeri; Luca Cecchetti; Teresa Corazzi; Claude Libert; Paolo Gresele
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

10.  Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis.

Authors:  Osamu Inoue; Kazuya Hokamura; Toshiaki Shirai; Makoto Osada; Nagaharu Tsukiji; Kinta Hatakeyama; Kazuo Umemura; Yujiro Asada; Katsue Suzuki-Inoue; Yukio Ozaki
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.